简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-11-21 14:16 Galderma Reports Record Net Sales of Over 3 B USD for the First Nine Months of 2023 With Strong Growth Momentum Across All Product Categories
2023-11-17 17:19 Morinaga Milk’s Probiotic Bifidobacterium breve B-3 Receives Approval of Individual Recognized Registration in South Korea
2023-11-17 13:56 Rapid Medical's TIGERTRIEVER™ Delivers First-Pass Success in Challenging Ischemic Stroke Patients with ICAD
2023-11-17 13:52 MicroVention Celebrates 10-Year Anniversary and Legacy of SOFIA™ Aspiration Catheters; More than 500,000 Procedures Performed Worldwide Across 170 Countries
2023-11-17 13:00 Exciting Progress | Gritgen Therapeutics Completed Patients Enrollment in China’s First Gene Therapy Investigator-Initiated Trial for Hemophilia A and also Achieved the First Patient Dosed in China Phase I Trial in Patients with Severe Hemophilia A
2023-11-17 10:25 Evidation Selected by Our Future Health as Participant Platform for UK’s Largest Health Research Program
2023-11-14 09:05 Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening
2023-11-10 09:41 Takeda’s ADZYNMA (ADAMTS13, recombinant-krhn) Approved by U.S. FDA as the First and Only Recombinant ADAMTS13 Enzyme Replacement Therapy for the Treatment of Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
2023-11-10 09:09 Aster Guardians Global Nursing Award 2024 Worth $250,000 to be Held in Bengaluru, India; Application Deadline Extended till 15th December
2023-11-09 14:23 Xenter Unveils Groundbreaking Investigational Dual Sensor Wireless GuideWire for Minimally Invasive TAVR Procedures at TCT 2023
2023-11-09 09:38 Governments Need to Keep up with Innovative Breakthroughs to Benefit Public Health, Reveals International Survey Commissioned by PMI
2023-11-08 13:44 Mary Kay Ash Foundation℠ Celebrates Five Years Shaping the Future of Cancer Research in Partnership With UT Southwestern Medical Center
2023-11-08 10:39 Takeda Announces Late-Breaking Data from Phase 2b Study of TAK-279, an Investigational, Oral, Once-Daily TYK2 Inhibitor, in Patients with Active Psoriatic Arthritis at American College of Rheumatology Convergence Annual Meeting
2023-11-07 08:43 HistoSonics Notches Significant Reimbursement Wins
2023-11-06 13:15 Pacific Prime Releases the State of Health Insurance Report 2023
2023-11-06 09:09 Trailblazing the Future of Healthy Aging Science: Timeline® Hosts the First Global Urolithin A Summit With a Full-day Virtual Experience
2023-11-06 09:03 Boehringer Ingelheim achieves major milestone in chronic kidney disease: aldosterone synthase inhibitor on top of empagliflozin delivers promising results in Phase II trial
2023-11-03 09:04 RGA Recognized for Outstanding Reinsurance Scheme and as Life Reinsurer of the Year in APAC
2023-11-03 08:53 GE HealthCare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies
2023-11-02 12:06 Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma

Business Wire Weibo

Press Releases

Latest Releases